Is "Curing Patients" a Good Business Model for Pharma?

02:37 EDT 17 Apr 2018 | Lab Soft News

An interesting point was made in a recent article that the stock market may "punish" companies like Gilead Sciences which has developed a drug called Harvoni to cure hepatitis C. The supposed reason for the punishment is that the prospects for drug profits will diminish as its highly effective use...

Original Article: Is "Curing Patients" a Good Business Model for Pharma?


More From BioPortfolio on "Is "Curing Patients" a Good Business Model for Pharma?"

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...